Evaluation of the Clinical Efficacy of Vachaharidradi Gana Kwatha Oral and Triphaladya Taila Matravasti in the Management of Medoroga w s r to Hyperlipidemia
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To reduce the symptoms of Hyperlipidemia
研究概览
简要总结
Medoroga is a condition in which there is an excessive production of medodhatu in the body. Accumulation of medodhatu in different parts of the body causes blockage of srotas which ultimately leads to poor nourishment of other dhatus. Kaphavardhaka ahara and vihara are the two main causes of Medoroga. Symptoms like KshudraSwasa, Trshna, Moha, Atinidra, Krathana, Sadana, Kshud, Atisweda, Dourgandhya, Alpa Prana and Alpa Maithuna are seen in Medoroga. In modern times, the way of life has changed drastically to quick nourishments and inactive tendencies throughout the world. Because of these factors, accumulation of medodhatu happens immensely. Hyperlipoproteinemia or Hyperlipidemia involves abnormally elevated levels of any or all lipids and / or lipoproteins in the blood. It is the most common form of Dyslipidemia. Hyperlipidemia is divided into Primary and Secondary subtypes. Primary Hyperlipidemia is usually due to genetic causes ( such as a mutation in receptor protein), while secondary Hyperlipidemia arises due to other underlying causes such as Diabetes, Thyroid, Renal disorders, Liver disorders and Cushing’s syndrome. Hyperlipidemia is one such condition that has been described as a possible risk factor for a wide range of diseases including Cardio vascular diseases, Cerebrovascular accident, Metabolic syndrome and Hypertension. Hyperlipidemia is described as elevated serum levels of Cholesterol or Triglycerides or both.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients having Prathyatma Lakshanas of Medoroga (Kshudra swasa, Trishna, Krathanam, Atinidra, Swedadikya).
- •2.Ptients having alteration in one or more component of the lipid profile.
- •Triglycerides 150-450mg/dl, Total Cholesterol 200-399 mg/dl, low density lipoprotein 100-190mg/dl
- •Patients indicted for Vasti karma
- •Patients who are willing to participate in the study and agree for consent sign.
排除标准
- •1.Patients with uncontrolled Non insulin dependent Diabetes Mellitus, Hypertension and Hypothyroidism.
- •2.Patients having Congenital hyperlipidemia ( like xanthomas ) ,Systemic disorders, Chronic kidney diseases, Drug induced hyperlipidemia eg; glucocorticoids etc.
- •and who is suffering from HIV, Carcinoma.
- •3.Known gene mutations are excluded.
- •4.Pregnant women and lactating mothers.
- •5.Patients contraindicated for vasti karma.
结局指标
主要结局
To reduce the symptoms of Hyperlipidemia
时间窗: 90 days
次要结局
- To Reduce raised Total cholesterols, triglycerides, LDL Counts(90 days)
研究者
Dr Rena Ravali
Dr BRKR Govt Ayurvedic Medical College & Hospital
